Search for: "MERRELL"
Results 21 - 40
of 598
Sort by Relevance
|
Sort by Date
10 Feb 2023, 4:44 am
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
31 Jan 2023, 7:39 am
Merrell Dow Pharms., Inc., 911 F.2d 941, 945 & n.6 (3d Cir. 1990) (“Epidemiological studies do not provide direct evidence that a particular plaintiff was injured by exposure to a substance. [read post]
22 Jan 2023, 8:19 am
Merrell Dow Pharmaceuticals. [read post]
17 Nov 2022, 7:42 am
Merrell Dow Pharms., Inc., 509 U.S. 579 (1993)] when determining whether [defendant’s expert] was qualified as an expert, focusing on the absence of reliable principles and methods,” then “contemplated how to balance [defendant’s expert’s] lack of credentials and training with [d]efendant’s right to present a defense. [read post]
11 Nov 2022, 2:46 pm
Merrell Dow Pharms., Inc., 509 U.S. 579, 595 (1993). [5] General Electric Co. v. [read post]
28 Aug 2022, 5:54 am
Merrell Dow Pharmaceuticals. [read post]
29 Jun 2022, 9:24 am
Merrell, No. 20-30183 (6-10-22)(Hurwitz w/Sung; dissent by Boggs). [read post]
17 Jun 2022, 2:09 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), legal scholars, judges, and lawyers have struggled with the structure and validity of expert opinion on specific causation. [read post]
9 May 2022, 5:01 am
Merrell Dow Pharms., Inc. (1993), the Supreme Court explained that Rule 702 imposes an obligation on a trial court to act as a gatekeeper to ensure that any and all scientific [or otherwise specialized] testimony or evidence admitted is not only relevant, but reliable. [read post]
7 May 2022, 5:01 am
Merrell Dow Pharmaceuticals, Inc. [read post]
3 May 2022, 10:28 am
Merrell Dow Pharmaceuticals, Inc. (1993), the Supreme Court explained that Rule 702 imposes an obligation on a trial court to act as gatekeeper, to ensure that any and all scientific [or technical or otherwise specialized] testimony or evidence admitted is not only relevant, but reliable. [read post]
8 Apr 2022, 3:36 am
Merrell, MBA, ACP, has been a real estate and finance paralegal for over 20 years. [read post]
29 Jan 2022, 6:24 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), Fed.Rules, Evid.Rules 104(a), 702. [read post]
5 Jan 2022, 4:33 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993).Where does the universe of disability terminate? [read post]
12 Dec 2021, 2:22 pm
In assessing an association for causality, the starting point is “an association between two variables, perfectly clear-cut and beyond what we would care to attribute to the play of chance. [read post]
3 Nov 2021, 9:05 pm
Merrell Dow Pharmaceuticals and Frye v. [read post]
1 Nov 2021, 11:14 am
[Or for that matter to women, to unmarried women, or to women based on age, race, national origin, religion, citizenship (other-"natural-born" or otherwise), and the like?] [read post]
17 Oct 2021, 2:17 pm
Merrell Dow Pharms., Inc., 911 F.2d 941, 958 (3d Cir. 1990); cf. [read post]
14 Oct 2021, 3:41 am
Meet the Author – Eva Merrell Eva M. [read post]
12 Oct 2021, 6:35 am
She has worked on many pharmaceutical products liability cases and acted as defense counsel for Merrell Dow Pharmaceuticals, Inc. [read post]
